首页 | 本学科首页   官方微博 | 高级检索  
检索        

术尔泰在急性穿孔性阑尾炎并弥漫性腹膜炎手术中的应用
引用本文:罗加兴,黄秋林,王志伟,肖友忠,刘润和.术尔泰在急性穿孔性阑尾炎并弥漫性腹膜炎手术中的应用[J].中国医学工程,2005,13(5):509-510.
作者姓名:罗加兴  黄秋林  王志伟  肖友忠  刘润和
作者单位:南华大学附属第一医院,普通外科,湖南,衡阳,421001
摘    要:目的探讨术尔泰在急性穿孔性阑尾炎并化脓性腹膜炎中的应用价值.方法将75例急性穿孔性阑尾炎并弥漫性腹膜炎患者随机分成两组,术中术尔泰应用组38例(治疗组),未应用术尔泰组37例(对照组).两组在切除阑尾后,用大量生理盐水冲洗腹膜至清亮,吸除残液,治疗组再加用200mL术尔泰浸泡5min吸除残液.腹膜缝合后治疗组和对照组分别用术尔泰及0.3%的稀碘伏切口浸泡3min.比较两组术后切口感染率,术后12 h后腹胀及粘连性肠梗阻再次手术发生率.结果治疗组38例中切口感染2例(5.3%),术后12 h后腹胀者4例(10.5%),因粘连性肠梗阻再次手术者1例(2.6%);对照组37例中切口感染10例(27.0%),术后12 h后腹胀者27例(73.0%),因粘连性肠梗阻再次手术者7例(18.9%);二者比较差异均有显著性.结论术尔泰具有抗炎,促进肠蠕动恢复,预防和减少肠粘连作用.

关 键 词:术尔泰  腹膜炎  治疗
文章编号:1672-2019(2005)05-0509-02
收稿时间:2005-01-20
修稿时间:2005年1月20日

Use of shuertai in operation of acute perforation appendicitis with diffuse peritonitis
LUO Jia-xing,HUANG Qiu-lin,WANG Zhi-wei,XIAO You-zhong,LIU Run-he.Use of shuertai in operation of acute perforation appendicitis with diffuse peritonitis[J].China Medical Engineering,2005,13(5):509-510.
Authors:LUO Jia-xing  HUANG Qiu-lin  WANG Zhi-wei  XIAO You-zhong  LIU Run-he
Abstract:Objective To value shuertai in the operation of acute perforation appendicitis with diffuse peritonitis. Methods] 75 patients with acute perforation appendicitis with diffuse peritonitis were divided into two groups, the treatment group (38 cases) and the control group (37 cases). The abdominal cavities of the treatment group were soaked with 200 mL shuertai for 5 min after the detection of the appendixs and washed with saline and incisional wound for 3 min, the abdominal cavities in control group were not soaked with shuertai and the incisional wounds were soaked with 0.3% Indophen for 3 min. Then compare the rate of the infection of incisional wound, abdominal distention after 12 h of postoperation and reoperation because of adhesive ileus between two groups. Results] The rates of the infection of incisional wound, abdominal distention after 12 h of postoperation and reoperation because of adhesive ileus were 5.3% (2/38), 10.5%(4/38) and 2.6% in the treatment group, but they were 27%(10/37), 86.5%(27/37) and 18.9%(7/37) in the control group, respectively. There were significantly differences between the two groups (P <0.01). Conclusion] Shuertai can reject infection, accelerate the etterocinesia and prevent and reduce the occurrenc of adhesive ileus.
Keywords:shuertai  peritonitis  treatment
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国医学工程》浏览原始摘要信息
点击此处可从《中国医学工程》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号